PULM
Pulmatrix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.44
+0.50%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$2.00
- Revenue estimate
- $1.5M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.29
- EPS estimate
- -$2.00
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +26.7%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$2.00 | -$0.29 | Beat 85.50% | — |
| May 15, 2026 | — | -$0.32 | — | — |
| Oct 16, 2025 | — | -$0.24 | — | — |
| Aug 6, 2025 | — | -$0.42 | — | — |
| May 15, 2025 | — | -$0.50 | — | — |
| Mar 21, 2025 | — | -$0.54 | — | $3.0K |
| Nov 8, 2024 | — | -$0.71 | — | $366.0K |
| May 10, 2024 | — | $0.23 | — | $5.9M |
| Nov 9, 2023 | -$1.05 | -$1.03 | Beat 1.90% | $1.8M |
| Aug 10, 2023 | -$1.23 | -$1.04 | Beat 15.45% | $1.8M |
| May 12, 2023 | — | -$1.22 | — | $1.5M |
| Nov 10, 2022 | -$1.51 | -$1.45 | Beat 3.97% | $1.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026